The Discounted Cash Flow (DCF) valuation of Arcus Biosciences Inc (RCUS) is (367.14) USD. With the latest stock price at 8.56 USD, the upside of Arcus Biosciences Inc based on DCF is -4389.0%.
Based on the latest price of 8.56 USD and our DCF valuation, Arcus Biosciences Inc (RCUS) is a sell. selling Arcus stocks now will result in a potential gain of 4389.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.2% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (891.20) - (233.85) | (367.14) |
| Upside | -10511.2% - -2831.9% | -4389.0% |